Vera Therapeutics, INC. (VERA) — SC 13D/A Filings
All SC 13D/A filings from Vera Therapeutics, INC.. Browse 4 SC 13D/A reports with AI-powered summaries and risk analysis.
SC 13D/A Filings (4)
-
Longitude Capital Ups Vera Therapeutics Stake to 17.9%
— Nov 4, 2024 Risk: medium
On November 4, 2024, Longitude Capital Partners IV, LLC, along with related entities and individuals including Patrick G. Enright and Juliet Tammenoms Bakker, f -
Sofinnova Amends Vera Therapeutics Stake
— Mar 26, 2024 Risk: medium
Sofinnova Venture Partners X, L.P. and its affiliates, including Dr. James I. Healy and Dr. Maha Katabi, have amended their Schedule 13D filing regarding Vera T -
Sofinnova Amends Vera Therapeutics Stake
— Feb 20, 2024 Risk: low
Sofinnova Venture Partners X, L.P. and its affiliates, including Sofinnova Management X, L.P. and Sofinnova Management X-A, L.L.C., filed an Amendment No. 3 to -
Longitude Capital Amends Vera Therapeutics Stake
— Feb 5, 2024
Longitude Capital Partners IV, LLC, along with its affiliates, filed an amended Schedule 13D on February 5, 2024, indicating a change in their beneficial owners
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX